Brief: Icosavax Announces Agreement To Be Acquired By Astrazeneca

Icosavax

12/12/2023 07:07

Dec 12 (Reuters) - Icosavax Inc  ICVX.O :
    * ICOSAVAX, INC. ANNOUNCES AGREEMENT TO BE ACQUIRED BY
ASTRAZENECA
    * DEAL REPRESENTING A TOTAL EQUITY VALUE OF UP TO $1.1
BILLION
INCLUDING CVR
    * ICOSAVAX - STOCKHOLDERS TO RECEIVE $15.00 PER SHARE IN
CASH AT
CLOSING PLUS NON-TRADEABLE CONTINGENT VALUE RIGHT (CVR) OF UP TO
$5.00 PER SHARE
    * ACQUISITION IS EXPECTED TO CLOSE IN Q1 OF 2024.
    * ICOSAVAX  - UPON SUCCESSFUL COMPLETION OF TENDER OFFER, A
SUBSIDIARY OF ASTRAZENECA WILL BE MERGED WITH AND INTO ICOSAVAX
    * ICOSAVAX -UPFRONT CASH PORTION OF CONSIDERATION REPRESENTS
EQUITY VALUE OF ABOUT $838 MILLION

Source text for Eikon:  ID:nGNX2T08W2 
Further company coverage:  ICVX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))